Home/Pipeline/Speedboat UltraSlim

Speedboat UltraSlim

GI Submucosal Dissection (SSD)

CommercialLaunched

Key Facts

Indication
GI Submucosal Dissection (SSD)
Phase
Commercial
Status
Launched
Company

About Creo Medical

Creo Medical's mission is to improve patient outcomes by applying its unique Kamaptive Advanced Energy technology to the emerging field of therapeutic endoscopy. The company has achieved commercial traction with its Speedboat devices, demonstrated significant health economic savings for providers like the NHS, and secured a strategic licensing deal with Intuitive Surgical. Its strategy combines innovative device development with a robust clinical education program (Pioneer Programme) to drive adoption and change the standard of care.

View full company profile